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Persistence of Mycobacterium tuberculosis in humans represents a major roadblock to elimination of tuber-
culosis. We describe identification of a locus in M. tuberculosis, mel2, that displays similarity to bacterial
bioluminescent loci and plays an important role during persistence in mice. We constructed a deletion of the
mel2 locus and found that the mutant displays increased susceptibility to reactive oxygen species (ROS). Upon
infection of mice by aerosol the mutant grows normally until the persistent stage, where it does not persist as
well as wild type. Histopathological analyses show that infection with the mel2 mutant results in reduced
pathology and both CFU and histopathology indicate that dissemination of the mel2 mutant to the spleen is
delayed. These data along with growth in activated macrophages and infection of Phox/ and iNOS/ mice
and bone marrow-derived macrophages suggest that the primary mechanism by which mel2 affects pathogen-
esis is through its ability to confer resistance to ROS. These studies provide the first insight into the
mechanism of action for this novel class of genes that are related to bioluminescence genes. The role of mel2
in resistance to ROS is important for persistence and dissemination of M. tuberculosis and suggests that
homologues in other bacterial species are likely to play a role in pathogenesis.
Despite extensive efforts to eradicate tuberculosis, caused by
Mycobacterium tuberculosis, worldwide and prevent the spread
of antibiotic-resistant strains, tuberculosis remains one of the
most frequent causes of death in humans. Currently, one-third
of the world’s population is thought to be persistently infected
with tuberculosis (6, 19, 20). A better understanding of the
mechanisms that lead to persistence in humans is needed be-
fore it will be possible to develop rational strategies to prevent
establishment of latency and block reactivation from it. Al-
though the mouse model, even when infected by the natural
low-dose aerosol route, does not replicate all aspects of patho-
genesis by tuberculosis, its cost-effectiveness and the presence
of numerous reagents make it an important tool for examina-
tion of the acute and persistent stages of infection (26, 50, 51).
As a result, much of our knowledge regarding the role of the
host in controlling infections as well as the bacterial factors
involved has been obtained using the mouse model (26, 31, 34).
Initially, tubercle bacilli encounter naïve alveolar macro-
phages in the mouse lung that produce low levels of reactive
oxygen species (ROS) and undergo an oxidative burst in re-
sponse to infection (8, 52). In the absence of ROS production,
there is a modest transient advantage for tuberculosis in the
lung, suggesting that ROS initially assist in the control of bac-
terial growth (16). This innate immune response does little to
prevent the growth of the bacteria in mouse lungs, since for the
first month after infection, bacterial numbers increase to a
million or more. This time point corresponds to the peaks in
the numbers of CD4 and CD8 T cells in the lung (38), maximal
tumor necrosis factor alpha (TNF-) levels (5, 32), and the
initiation of a strong cell-mediated immune response. The
cell-mediated immune response leads to control of bacterial
growth, higher gamma interferon (IFN-) levels and tubercu-
losis persistence at stable numbers for between 1 and 2 years
(38) before reactivation, most likely the result of a weakened
immune system due to the age of the mice (49). TNF- (44, 57)
and IFN- (15, 27) levels are important for controlling tuber-
culosis growth and maintenance of the persistent state in the
mouse model of infection. One of the reasons that TNF- and
IFN- help to control tuberculosis is that they provide signals
for the production of both ROS and reactive nitrogen species
(RNS) by macrophages (8, 25, 28, 32, 40, 65). Although M.
tuberculosis is considered relatively resistant to ROS, muta-
tions that impact those bacterial pathways involved in resis-
tance can affect virulence (21, 33, 39, 47, 53). In contrast to
ROS, RNS, produced by the nitric oxide synthase (iNOS) that
is induced by IFN-, inhibit the growth of mycobacteria and
are critical to maintenance of the persistent state in mice (7, 8,
22, 27, 29, 42). Although the role of RNS in the control of M.
tuberculosis growth in mice seems well proven, the involvement
of RNS in human (58) and in other animal, including guinea
pig (36, 68), tuberculosis models is less clear, possibly because
the presence of NO has been difficult to demonstrate (9, 24, 46,
54, 67). These observations suggest that M. tuberculosis genes
involved in resistance to either ROS or RNS will play a role in
persistence.
We recently identified a locus in Mycobacterium marinum,
designated mel2, that affects resistance to ROS and RNS (61,
62). Interestingly, this locus has three genes, melF, melG, and
melH, with similarity to the luxA, luxG, and luxH biolumines-
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cence genes, respectively, in other bacterial species (23). The
luciferase (luxA) genes in other organisms can affect resistance
to ROS (41, 55, 66) in addition to their role in biolumines-
cence. Bacterial luciferases are thought to scavenge H2O2 in a
catalase-like reaction in which the enzyme-bound flavin mono-
nucleotide (FMN) hydroperoxide and H2O2 decompose, re-
leasing water and oxygen, to the enzyme-bound hydroxy-FMN
that spontaneously decomposes to water, light, and enzyme-
bound FMN (66). These observations suggest the intriguing
possibility that the mel2 locus will be important for tuberculosis
pathogenesis, since M. tuberculosis must resist ROS produced
by the host immune response during infections. In order to test
this hypothesis, we isolated an M. tuberculosis mutant in the
mel2 locus and confirmed the loss of mel2 activity by an in-
crease in ROS susceptibility. The mel2 mutant was evaluated
for its role in virulence using the mouse model and macro-
phage infection in vitro. Mice and macrophages deficient in
ROS and RNS were used to probe the primary host defense
mechanisms that the mel2 locus is necessary to protect tuber-
culosis against. We found that the mel2 mutant displays in-
creased susceptibility to ROS and is defective for growth in
activated macrophages. Our data also suggest that the mel2
locus plays an important role during the persistence and dis-
semination of M. tuberculosis. The primary mechanism by
which mel2 affects these events appears to be resistance to
ROS. Overall, these studies provide evidence for the role of
bioluminescence-related genes, such as mel2, in protecting M.
tuberculosis, and most likely other bacterial species that carry
similar genes, against ROS.
MATERIALS AND METHODS
Strains and growth conditions. M. tuberculosis strain Erdman (ATCC 35801)
and derivatives were grown in 7H9 broth (Difco, Detroit, MI) supplemented with
0.5% glycerol, 10% OADC (oleic acid dextrose complex without catalase), and
0.05% Tween 80 (M-OADC-TW broth) or Middlebrook 7H9 supplemented with
10% OADC and 15 g/liter Bacto agar (M-OADC agar) or on 7H11 selective agar
(Difco). The composition of the OADC supplement used is identical to that
described in the Difco manual (18) with the exception that it does not contain
catalase. A stock solution of 1% (wt/vol) oleic acid is made in 0.2 N NaOH prior
to adding 5 ml of the stock solution per 100 ml final volume of the OADC
supplement. Prior to use in assays, aliquots of liquid cultures are taken into
sealed tubes and vortexed vigorously for 2 min followed by centrifugation at
2,000  g for 1 s. Samples of bacteria are taken from the top half of the resulting
culture to ensure that single-cell suspensions with few clumps of bacteria are
used for assays. When necessary media and plates were supplemented with 50
g/ml hygromycin and 25 g/ml kanamycin. Frozen stocks were prepared from
strains for experiments by growth standing at 37°C until an optical density at 600
nm of 0.5 and stored in aliquots at 80°C until use. Mycobacterium smegmatis
strain mc2155 cultures were grown in M-OADC-TW (23) for 3 days at 37°C prior
to use for the propagation of shuttle phasmids.
Cell lines, primary cells, and culture conditions. The murine macrophage cell
line J774A.1 (ATCC TIB67) was maintained at 37°C and 5% CO2 in high glucose
Dulbecco’s modified Eagle medium (DMEM; Gibco, Bethesda, MD) supple-
mented with 10% heat-inactivated fetal bovine serum (FBS; Gibco) and 2 mM
L-glutamine. Mouse bone marrow-derived macrophages (BMDM) were col-
lected from the femurs, tibiae, and humeri of infected mice as described previ-
ously (56). Briefly, the marrow was flushed out with cold sterile phosphate-
buffered saline (PBS), and cells were collected by centrifugation at 800 rpm at
room temperature. The cell pellets were washed twice with ACK buffer (0.15 M
NH4Cl, 0.01 M KHCO3, 0.01 mM Na2EDTA), followed by an additional wash
with RPMI (Gibco) supplemented with 10% heat-inactivated FBS, 1% L-glu-
tamine, 5% L-929 supernatant, and 1% penicillin/streptomycin (Mediatech,
Inc.). The cells were suspended in RPMI containing 30% L-929 supernatant and
allowed to differentiate for 7 days to obtain BMDM. Human peripheral blood
monocyte-derived macrophages (PBMC) were isolated as described previously
(10, 11). Basically, PBMC were isolated from 50 ml of human blood obtained
from healthy volunteers. The mononuclear cell fraction was purified by centrif-
ugation in Ficoll at 700  g for 30 min. The PBMC band was removed, washed
twice, and suspended in RPMI plus 0.1% heat-inactivated human serum to 106
cells/ml. Cells were seeded in 24-well dishes and incubated for 2 h at 37°C.
Nonadherent cells were removed by washing, and experiments were carried out
in RPMI plus 5% heat-inactivated human serum.
Construction and complementation of the mel2 mutant. The mel2 mutant
M. tuberculosis strain was constructed by allelic exchange using the shuttle phas-
mid phAE87 as described previously (1, 30). Basically, a 7,034-bp region begin-
ning 60 bp from the putative translational start of melF, the first gene in mel2,
and ending 30 bp from the translational stop of melK, the last gene in mel2, was
replaced with a hygromycin resistance (Hygr) cassette. The presence of the
appropriate mutation in the chromosome of M. tuberculosis was confirmed by
Southern blot analyses using the probe indicated in Fig. 1 and PCR from within
the Hygr cassette into the melF upstream sequence and within the deleted region.
Southern blot analyses identified a 14.3-kbp NheI fragment in wild-type M.
tuberculosis and a 6.9-kbp NheI fragment in the mel2 mutant, as expected.
The complementation of the mel2 mutant was achieved using a single-copy,
site-specific integrating construct that carries the endogenous promoter for mel2.
This complementing construct, designated pJDC75 (Fig. 1), was made by cloning
the entire mel2 locus along with 181 bp upstream of the translational start for
FIG. 1. Organization and similarity of the mel2 locus in M. marinum and M. tuberculosis as well as the structure of the mel2 deletion mutant
and the single-copy, site-specific integrating plasmid (pJDC75) used for the complementation of the mel2 mutant. The identity at the amino acid
level between M. marinum and M. tuberculosis for each open reading frame within this locus is 68%, whereas the adjoining regions display no
similarity between these two mycobacterial species (shown by the gray bar). Arrows indicate the deduced direction of transcription and length of
each open reading frame. The distance between the two NheI sites producing the 14.3-kbp fragment in wild-type M. tuberculosis and the 6.9-kbp
fragment in the mel2 deletion mutant observed by Southern analysis is indicated by the double arrow line. The position of the Hygr gene is
indicated. Dashed lines indicate the positions of the deletion produced by allelic exchange. The line designated P indicates the position of the probe
used for Southern analyses.
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melF, the putative promoter region for mel2, into the NheI site in the L5
attachment site integrating vector pYUB178, which carries a kanamycin resis-
tance gene (61). The mel2 mutant was transformed with pJDC75 and transfor-
mants selected by plating on kanamycin and Hyg. The presence of pJDC75 in the
mel2 mutant was confirmed by PCR and by the ability to confer wild-type
resistance to ROS (Fig. 2).
Determination of ROS susceptibility. The susceptibility of M. tuberculosis to
ROS was determined essentially as described previously (62). Basically, M. tu-
berculosis strains were incubated at a concentration of 106 CFU/ml in 1 mM, 5
mM, or 10 mM H2O2; 5 mM tert-butyl hydroperoxide (t-BOOH); or 5 mM
cumene peroxide in M-OADC-TW for 30 min at 37°C. The numbers of viable
bacteria were determined before and after treatment to measure the percentage
survival for each strain by plating dilutions on M-OADC agar.
Growth assays in macrophages. Growth of M. tuberculosis in mouse and
human macrophages was evaluated in J774A.1 cells, BMDM, and PBMC in a
manner similar to that described previously (61). J774A.1 cells were seeded at
2.5 105 cells/well in 24-well tissue culture plates and incubated overnight (ON)
at 37°C in DMEM. In the case of the activated cells, the medium was changed,
100 U murine IFN- was added, and the cells were incubated ON at 37°C. The
medium was then changed again, 1 g/ml lipopolysaccharide (LPS) was added,
and the cells were incubated ON at 37°C. The medium was then changed just
prior to infection with 0.2 ml that contains 105 bacteria, equivalent to a multi-
plicity of infection of approximately 0.1 (bacteria/cell). The bacteria were incu-
bated with the cells for 30 min at 37°C and washed twice with warm PBS, and the
medium was replaced with DMEM plus 1% FBS. The cells in a triplicate set of
wells were lysed at each time point for each strain with 0.1% Triton X-100.
Dilutions were made and plated on M-OADC agar plates to determine the
number of viable bacteria present. The medium on the cells was replaced every
3 days throughout the course of the long-term growth experiments. The BMDM
were treated in the same manner as the J774A.1 cells, except that they were
directly seeded at 1  106 cells/well and incubated overnight prior to activation
with 100 U IFN- in RPMI medium. Human PBMC were used in a similar
manner; they were seeded at 1  106 cells/well and incubated overnight prior to
activation with 40 U human IFN- in RPMI medium. Cell viability throughout all
the experiments was 90% and did not appear to play a role in the differences
observed for M. tuberculosis growth under these conditions.
Measurement of ROS and RNS levels. Levels of ROS and RNS produced by
macrophages were determined as described previously (61). Basically, BMDM
were stimulated with 100 U mouse IFN- plus 1 g LPS or 105 M. tuberculosis
cells for 24 h at 37°C. ROS levels were evaluated by measuring H2O2 production
with the horseradish peroxidase-dependent oxidation of phenol red and by com-
paring the levels to a standard curve developed with known concentrations of
H2O2. The levels of RNS were determined by measuring the NO2 content
through a reaction with Griess reagent and comparing the levels to a standard
curve constructed using NaNO3 to determine the actual concentration of NO2.
Measurement ofM. tuberculosis LPO levels. Lipid hydroperoxides (LPO) were
measured in the M. tuberculosis cells by extraction into chloroform and direct
quantification using the LPO assay kit (Cayman Chemical) as recommended by
the manufacturer. A total of 106 CFU of each bacterial strain were treated with
either 1 mM H2O2 or 10 mM t-BOOH for 16 h at 37°C. The bacteria were mixed
with an equal volume of a saturated methanolic solution of extract R and
extracted with 2 volumes of ice-cold chloroform. Dilutions were made with
chloroform-methanol (2:1, vol/vol) and aliquots analyzed with thiocyanate as the
chromogen by reading absorbance at 500 nm. The concentrations of LPO in each
sample were then determined using a standard curve constructed using 13-
hydroperoxy-octadecadienoic acid as a standard.
Low-dose aerosol infection of mice. Five- to seven-week-old female C57BL/6,
inducible nitric oxide synthase negative (iNOS/), and NADPH oxidase subunit
gp91 negative (Phox/) mice were obtained from Jackson Laboratories. All
animals were housed in polycarbonate microisolator cages in a temperature-,
humidity-, and light-controlled environment. There were five animals in each
experimental group. Animals were assigned randomly to experimental groups,
allowed to acclimate to the facilities for 1 week and fed commercial chow and tap
water ad libitum. Low-dose infections were carried out by the aerosol route to
deliver between 10 and 50 CFU to the lungs using a Madison chamber aerosol
generation device, in a manner similar to that described previously (13). Portions
of the lungs and spleens were homogenized in PBS and dilutions plated on 7H11
selective medium to determine the numbers of bacteria present at each time
point.
Histopathological analyses. Histopathology was carried out to evaluate the
pathology of M. tuberculosis-infected mice essentially as described previously
(12). Basically, portions of the lungs and spleens were fixed in 10% neutral
buffered formalin for embedding in paraffin, sectioning at 5 m, and staining
with either hematoxylin and eosin or acid-fast stain. A blinded examination of at
least three serial sections from each mouse was carried out to evaluate the
numbers of granulomas, the presence of acid-fast bacilli, the degree of mixed cell
infiltrate, and inflammation.
Statistical analyses. All experiments were carried out in triplicate and re-
peated at least three times, except where specifically noted. The significance of
the results was determined using the Student’s t test or analysis of variance, as
needed. P values of 	0.05 were considered significant.
RESULTS
Analysis of the mel2 locus and identification of the M. tu-
berculosis genes. The deduced amino acid sequences of the six
putative genes within the M. marinum mel2 locus, melF to
melK, were each individually used to search the M. tuberculosis
genome for similar genes. A region of 11,122 bp was identified
in the M. tuberculosis genome where the six genes within the
mel2 locus are in the same arrangement as in the M. marinum
chromosome (23). The entire region, from Rv1936 to Rv1941
and four putative genes upstream of the mel2 locus, has high
similarity to the M. marinum chromosome, with greater than
68% identity compared to the deduced amino acid sequences
of all 10 genes and exactly the same gene order and deduced
direction of transcription (Fig. 1). These observations suggest
that the function of all 10 of the putative genes within this
region is evolutionarily conserved between M. marinum and M.
tuberculosis and that their functions may be related to each
other. Interestingly, through the course of these analyses, we
identified another locus that is present in both M. marinum and
M. tuberculosis but has only two genes, Rv3618 and Rv3617,
similar to the melF and melH genes in mel2, respectively. The
melH gene is an epoxide hydrolase, also known as ephB, and its
homologue, Rv3617, is annotated as ephA in the M. tuberculo-
sis genome. The melF gene and its homologue, Rv3618, are
both annotated as hypothetical proteins similar to LuxA-re-
lated putative monooxygenase. We suggest that an appropriate
designation of Rv3618 is melF2 and that the melF gene located
FIG. 2. Susceptibility of the mel2 mutant to H2O2, t-BOOH, and
cumene peroxide (Cumene). The percentage of viable M. tuberculosis
bacteria was determined by measuring bacterial CFU after a 30-min
treatment with each compound. The percentage of survival is calcu-
lated as (CFU T30/CFU T0)  100, where CFU T30 is the number of
CFU at the 30-min time point and CFU T0 is the number of CFU at
the 0-min time point. Three asterisks indicate a P of 	0.001 and two
asterisks indicate a P of 	0.01, which are significantly different from
that for wild-type M. tuberculosis under the same treatment conditions.
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in the mel2 locus could be designated melF1. A search of the
available sequence data at NCBI resulted in the identification
of 47 bacterial genera that carry genes similar to melF that are
annotated as encoding hypothetical proteins. Interestingly,
more than 70% of these bacteria are known pathogens (49%)
or symbionts (21%), suggesting that melF may play a role
during bacterial interactions with eukaryotes. These observa-
tions suggest that information regarding the function of melF
in M. tuberculosis is relevant to genes of unknown function that
are widespread in bacterial species, particularly pathogens and
symbionts.
Construction and characterization of the M. tuberculosis
mel2 mutant. Phage transduction was used to construct a de-
letion of the entire mel2 locus in M. tuberculosis (Fig. 1). The
presence of the appropriate mutation in the chromosome was
confirmed by PCR and Southern analyses (data not shown).
The mel2 deletion mutant did not display a defect in growth or
any difference in clumping in laboratory medium compared to
wild-type M. tuberculosis (data not shown). A single-copy inte-
grating construct, pJDC75, that carries the entire mel2 locus and
its promoter was used to complement the mel2 mutation. The
transformation of pJDC75 into the mel2 mutant was confirmed
by PCR prior to conducting further studies with the wild-type,
mutant, and complementing strains in parallel (data not shown).
As expected, theM. tuberculosismel2mutant is more susceptible
to H2O2 (P 	 0.001) than the wild type (Fig. 2), suggesting that
the M. tuberculosis mel2 locus plays a role in the defense against
ROS. Data obtained with other ROS-generating compounds, cu-
mene hydroperoxide and t-BOOH, were similar to those obtained
with H2O2. Thus, we have successfully deleted the entire M.
tuberculosis mel2 locus, confirmed the structure of this mutated
region, and obtained evidence that this mutation affects suscep-
tibility to ROS.
mel2 plays a role in persistence in C57BL/6 mice. Since
bioluminescence pathways in other bacteria can affect suscep-
tibility to ROS and the mel2 mutation affects resistance to
ROS, it is likely that mel2 will also affect virulence. We eval-
uated the role of mel2 in virulence using the low-dose (	100
bacteria per lung) aerosol infection model for tuberculosis in
C57BL/6 mice. We found that during the first 4 weeks postin-
fection, the mel2 mutant displays higher (P 	 0.001) bacterial
numbers in the lung compared to those of wild-type M. tuber-
culosis (Fig. 3). However, the mel2 mutant does not persist as
well as the wild type and displays significantly (P 	 0.01) lower
numbers of bacteria in the lung at 84 to 147 days postinfection.
Although these results were intriguing, we were concerned
that, in experiment 1, the infectious dose with the mel2 mutant
was inadvertently more than sixfold higher than that for the
FIG. 3. Growth and persistence of mel2 mutant in C57BL/6 mice. Data shown are for three experiments with five animals in each group for
each experiment. The complementing strain (mel2::pJDC75) contains the complete mel2 locus integrated site specifically in a single copy on the
chromosome. The increase is calculated for both the lung (A, B and D) and spleen (C and E) based on the initial numbers of bacteria that seeded
the lungs on day 1 after low-dose aerosol infection. One asterisk indicates a P of 	0.05, two asterisks indicate a P of 	0.01, and three asterisks
indicate a P of 	0.001, which are significantly different from that for wild-type M. tuberculosis in the same organ.
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wild type, possibly affecting growth in the lungs. In experiment
1 and two subsequent pilot infection studies (data not shown),
we found that, although nearly identical concentrations of bac-
teria were used for aerosolization, the mel2 mutant always
seeded the lungs at higher levels than the wild type. Although
we remain uncertain of the reasons for this phenomenon, we
corrected for seeding efficiency by reducing the concentration
of the mel2 mutant used for infection by twofold, resulting in
nearly identical numbers (
25%) of bacteria initially seeding
the lungs at day 1 in experiments 2 and 3. Using these condi-
tions, we found that when day 1 bacterial numbers are similar,
the mel2 mutant does not differ from the wild type in survival/
growth in the lung during the first 4 weeks postinfection (Fig.
3) but does display a defect in persistence (P 	 0.001). Inter-
estingly, bacterial numbers in the spleen at 4 weeks were less
for the mel2 mutant than the wild type (P 	 0.001 in experi-
ment 2 and P 	 0.05 in experiment 3), suggesting that mel2
plays a role in the dissemination and/or susceptibility to ex-
trapulmonary immune components. These observations sug-
gest that the M. tuberculosis mel2 locus plays a role in persis-
tence within the lung and dissemination to or survival within
extrapulmonary tissues.
The mel2 mutation affects pathogenesis in mice. Tissues
from the lungs and spleens of mice infected with wild-type M.
tuberculosis and the mel2 mutant were examined for patholog-
ical changes at 4 and 20 weeks postinfection. Hematoxylin and
eosin sections were coded for blinded examination and scored
for the degree of inflammation and mixed lymphocytic infil-
trates, and the numbers of granulomas were quantified for
each section. We found that at 4 weeks postinfection, the lungs
of mel2 mutant-infected mice display fewer granulomas (mean,
2
 1) than do those of mice infected with the wild type (mean,
5 
 2). Those granulomas present were smaller and contained
fewer lymphocytes, foamy macrophages, and giant cells than
granulomas in the wild-type lungs (Fig. 4). Inflammation was
less pronounced, with less extensive tissue damage and consol-
idation resulting in more numerous intact alveoli in regions
near granulomas. At 20 weeks postinfection, this pattern is
more obvious with more discrete and smaller granulomatous
regions present in lungs infected with the mel2 mutant and
nearly normal tissue surrounding the granulomas. Ziehl-
Neelsen stains of these same tissues revealed that the lung
granulomas of mice infected with the wild type and the mel2 M.
tuberculosis mutant contain similar numbers or, possibly, the
granulomas of mice infected with the mel2 mutant contain
somewhat more bacteria than do those of mice infected with
the wild type. These observations correspond well with the
FIG. 4. Histopathological changes in the lungs and spleens of mice
infected with wild type (WT) and mel2 M. tuberculosis. Hematoxylin
and eosin stains were use to evaluate the pathology in tissues from
experiment 2 (Fig. 3) at 4 (A) and 20 weeks (B) postinfection. The size
bar in panel A (WT, Lung 4 wks) is 100 m and applies to all panels
in A and B. Filled arrowheads indicate follicles in the spleen, and
unfilled arrowheads indicate foci of antigen-presenting cells, most
likely macrophages or dendritic cells. More extensive pathology was
observed in the lungs of mice infected with wild-type M. tuberculosis
compared to that of the mel2 mutant. The spleens of mice infected
with wild-type M. tuberculosis display foci of antigen-presenting cells at
4 weeks postinfection, whereas mice infected with the mel2 mutant
display less defined foci only at 20 weeks postinfection. (C) Acid-fast
stains were used to localize the bacteria in wild-type M. tuberculosis-
and mel2 mutant-infected tissues. The size bar in panel C (WT, Lung
4 wks) is 50 m and applies to all panels in panel C. Although there
were fewer granulomas in the lungs of the mel2 mutant-infected mice,
almost double the number of bacteria was present within them. The
foci of antigen-presenting cells in the spleen contain similar numbers
of bacteria in both wild-type and mel2 mutant-infected mice, but these
foci and the bacteria that they contain were only found in the spleens
of mel2 mutant-infected mice at 20 weeks and were not present at 4
weeks postinfection.
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presence of similar numbers of bacteria by CFU but with fewer
granulomas in the mel2 mutant-infected mice than in the wild-
type-infected mice. The spleens of mice infected with the mel2
mutant displayed few periarteriolar foci of macrophages or
antigen-presenting cells within T follicles compared with those
of mice infected with the wild type at 4 weeks postinfection
(Fig. 4). However, by 20 weeks postinfection the numbers of
such foci in mice infected with the mutant were similar to those
of mice infected with the wild type, though in the case of the
mel2 mutant-infected mice, the foci were less circumscribed.
Acid-fast bacteria were usually present within what appeared
to be antigen-presenting cells in these foci when they were
observed, suggesting that M. tuberculosis travels to the spleen
within these cells. These data suggest that the mel2 mutant
displays decreased lung pathology and delayed dissemination
to the spleen.
Survival of M. tuberculosis in activated macrophages de-
pends upon mel2. The observation that mel2 is not required
initially to combat the innate immune response after infection
by aerosol with M. tuberculosis but is required for persistence
suggests that mel2 allows M. tuberculosis to survive once an
acquired immune response is generated or for the metabolic
transition to a dormant state necessary for persistence. Since
M. tuberculosis is thought to grow and replicate primarily
within macrophages, we first examined the role of acquired
immunity in the elimination of the mel2 mutant during persis-
tence in the lung by evaluating the susceptibility of this mutant
to resting and activated macrophages (Fig. 5). Although the
growth/survival of the mel2 mutant at 12 days in resting murine
J774A.1 macrophages is somewhat less than that of the wild
type (P 	 0.01), it is possible that this observation is due to the
intrinsic activation of these macrophages by M. tuberculosis
infection itself, since no difference in growth/survival is ob-
served at 6 days. Growth in activated macrophages is defective
for the mel2 mutant as early as 2 days postinfection up to 14
days (P 	 0.01). The growth of the mel2 mutant was also
examined in primary cells from humans and mice to determine
whether this growth defect was due to a specific characteristic
of the J774A.1 cell line, murine cells or generally applicable to
all macrophages (Fig. 6). The mel2 mutant displays a more
severe growth defect (P 	 0.001) in both human PBMC and
FIG. 5. Growth of wild-type M. tuberculosis, mel2, and mel2-com-
plementing (mel2::pJDC75) strains in resting (A) and activated
(B) J774A.1 cells. Data and error bars represent the means and stan-
dard deviations, respectively, of the results from triplicate samples in a
representative experiment carried out three times with similar results.
Two asterisks indicate a P of 	0.01 and three asterisks indicate a P of
	0.001, which are significantly different from that for wild-type M.
tuberculosis.
FIG. 6. Growth of wild-type M. tuberculosis, mel2, and mel2-com-
plementing (mel2::pJDC75) strains in activated human PBMC (A) and
activated strain C57BL/6 murine BMDM (B). Data and error bars
represent the means and standard deviations, respectively, of the re-
sults from triplicate samples in a representative experiment carried out
three times with similar results. Three asterisks indicate a P of 	0.001,
which is significantly different from that for wild-type M. tuberculosis.
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C57BL/6 mouse BMDM than was observed in the J774A.1
macrophage cell line, suggesting that the mel2 locus is impor-
tant for the interaction of M. tuberculosis with primary acti-
vated macrophages and that the J774A.1 cells are less discrim-
inatory for this phenotype.
The mel2 locus is important for ROS and RNS resistance.
There are several potential mechanisms by which mel2 could
allow the growth of M. tuberculosis in activated macrophages,
resistance to ROS, resistance to RNS, resistance to both, re-
sistance to other bactericidal pathways, or modification of cel-
lular trafficking pathways. We first chose to determine the role
of ROS and RNS in the mel2 phenotype, since the mel2 mutant
is more susceptible to ROS in culture. We chose primary
BMDM for these studies because of the clear phenotype that
mel2 displays in these cells. We measured the levels of produc-
tion of ROS and RNS by wild-type C57BL/6, iNOS/, and
Phox/ BMDM with and without activation with IFN- plus
LPS or in the presence of M. tuberculosis (Fig. 7). Both acti-
vation with IFN- plus LPS and M. tuberculosis induce signif-
icant levels of ROS in wild-type and iNOS/ BMDM but not
Phox/ BMDM (P 	 0.001). However, RNS were only in-
duced after activation with IFN- plus LPS in wild type and
Phox/ BMDM but not iNOS/ BMDM (P 	 0.001). In-
terestingly, the levels of ROS produced by iNOS/ mice after
activation were more than four times higher than those of the
wild type, suggesting that the absence of iNOS results in the
compensatory overproduction of ROS after activation. We
found that the mel2 mutant still displays a defect in both
Phox/ and iNOS/ activated BMDM (P 	 0.001), though
this defect is less obvious in both cell types than in wild-type
BMDM (Fig. 8). These data provide evidence that mel2 plays
a role in resistance to both ROS and RNS in activated mac-
rophages.
mel2-mediated ROS resistance is involved in dissemination.
Although our observations indicate that mel2 is important for
resistance to ROS and RNS in activated macrophages in vitro,
it is unclear how ROS and RNS production impact the kinetics
of infection, since M. tuberculosis initially interacts with resting
macrophages that may not produce high levels of ROS and
FIG. 7. Production of H2O2 (A) and NO2
 (B) by BMDM from
C57BL/6, iNOS/, and Phox/ mice untreated and treated with
murine IFN- plus LPS or M. tuberculosis. Data and error bars repre-
sent the means and standard deviations, respectively, of the results
from quadruplicate samples in a representative experiment carried out
two times with similar results. Three asterisks indicate a P of 	0.001
and one asterisk indicates a P of	0.05, which are significantly different
from that for untreated BMDM from the same mouse strain.
FIG. 8. Growth of wild-type M. tuberculosis, mel2, and mel2-com-
plementing (mel2::pJDC75) strains in activated strain C57BL/6 genetic
background Phox/ (A) and iNOS/ (B) murine BMDM. Data and
error bars represent the means and standard deviations, respectively,
of the results from triplicate samples in a representative experiment
carried out two times with similar results. Three asterisks indicate a P
of 	0.001, which is significantly different from that for wild-type M.
tuberculosis.
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RNS and only subsequently is faced with a strong immune
response. We evaluated the kinetics of infection in Phox/
and iNOS/ mice by wild-type M. tuberculosis and the mel2
mutant using the low-dose aerosol infection model (Fig. 9). We
found that in the lungs of Phox/ mice, the mel2 mutant
behaves similarly to the wild type. Although there is an initial
defect in the numbers of bacteria in the spleens of Phox/
mice, this defect is modest at 4 weeks (P 	 0.05) and is not
significant at later time points. In contrast, iNOS/ mice
display a difference between the mel2 mutant and the wild type
in the lung and spleen very similar to that seen in C57BL/6
mice (P	 0.001). These observations suggest that mel2 is more
important for resistance to ROS than RNS and that resistance
to ROS and RNS is important for dissemination to the spleen.
mel2 is involved in the protection of tuberculosis from lipid
oxidation. If the primary role of mel2 is in the protection of M.
tuberculosis from ROS, treatment with H2O2 should affect not
only bacterial viability but also the levels of oxidized molecules
within the bacterial cell. We examined the levels of oxidized
lipids in the form of LPO within M. tuberculosis and the mel2
mutant after treatment with ROS (Fig. 10). Under normal
growth conditions, the mel2 locus does not affect the basal
levels of LPO in M. tuberculosis. In contrast, in the presence of
ROS, represented by H2O2 and t-BOOH, an organic peroxide
that decomposes to alkoxyl and peroxyl radicals as well as
H2O2, the levels of LPO are higher in the mel2 mutant than in
wild-type M. tuberculosis (P 	 0.01). Under the conditions
used, despite the fact that the levels of H2O2 cause very little
loss of viability in wild-type M. tuberculosis (Fig. 2), the levels
of LPO are significantly higher in all strains than in the un-
treated bacteria (P 	 0.001). These observations demonstrate
that M. tuberculosis is susceptible to the oxidative damage of
lipids and that the mel2 locus is involved in the prevention or
repair of ROS-mediated lipid oxidation.
DISCUSSION
These studies found that the M. tuberculosis mel2 locus,
which is a member of a new class of bioluminescence-related
genes present in numerous nonbioluminescent pathogens and
symbionts, plays a role in M. tuberculosis persistence and dis-
semination in the mouse model of infection. Both of these
functions during M. tuberculosis pathogenesis may be the result
of effects on susceptibility to ROS and RNS produced by host
cells that are responding to infection. Overall, the mechanism
by which mel2 affects persistence during pathogenesis is pri-
marily through resistance to ROS and secondarily to RNS.
This mechanism is supported by the following four different
FIG. 9. Growth and persistence of mel2 mutant in Phox/ (A, B) and iNOS/ (C, D) mice. Data shown are the means and standard
deviations of the results from four animals in each group for each experiment. The increase is calculated for both the lung and spleen based on
the initial numbers of bacteria that seeded the lungs on day 1 after low-dose aerosol infection. An asterisk indicates a P of	0.05 and three asterisks
indicate a P of 	0.001, which are significantly different from that for wild-type M. tuberculosis in the same organ.
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pieces of evidence: (i) our previous observations in M. mari-
num (61, 62), (ii) the increased susceptibility of the mel2 mu-
tant to ROS, (iii) the recovery of a wild-type phenotype of the
mel2 mutant in Phox/ mice, and (iv) the higher levels of
ROS-mediated LPO within the bacterial cell. Interestingly, no
greater role for mel2 in resistance to ROS was observed in M.
marinum, suggesting that there are differences in the mecha-
nisms by which M. tuberculosis and M. marinum resist ROS and
RNS. This is not surprising, since the M. tuberculosis oxyR
gene, a key regulator of the response to ROS and RNS in other
bacterial species, is inactivated but in M. marinum is intact (17,
59). This difference impacts the expression of other important
genes, including ahpC (60), which is involved in resistance to
peroxynitrite, a product of nitric oxide and hydrogen peroxide.
These observations, along with the data obtained in the current
study, suggest that mel2 is important for resistance to ROS
produced as part of an acquired immune response.
An unexpected and intriguing observation that we made in
this study is that mel2 affects the dissemination of M. tubercu-
losis to the spleen. In all cases, including wild-type C57BL/6,
Phox/, and iNOS/ mice, the dissemination of the mel2
mutant to the spleen is delayed compared to that of wild-type
M. tuberculosis. The two most likely possibilities that could
explain why mel2 affects dissemination are that extrapulmo-
nary tissues have a greater ability to produce ROS and RNS at
early time points postinfection or that mel2 is involved in the
repair of bacterial components that play a role in dissemina-
tion. The first possibility, that extrapulmonary sites have
greater bactericidal activity, is consistent with data suggesting
that alveolar macrophages are less bactericidal than peritoneal
blood monocyte-derived macrophages or PBMC (14, 48). This
difference in bactericidal activity in different tissues may be a
consequence of the need to prevent hyperresponsiveness in
pulmonary tissues, which is thought to be controlled primarily
by alveolar macrophages themselves (35, 64). The second pos-
sibility, that mel2 is involved in the repair of M. tuberculosis
components involved in dissemination, is consistent with our
observation that the overexpression or mutation of mel2 in M.
marinum affects the infection of macrophages (23). On the
surface, it may seem perplexing as to why a locus involved in
susceptibility to ROS would affect host-cell infection, but con-
sidering that this phenotypic effect may be indirect through the
repair of oxidized lipids at the mycobacterial surface that are
involved in host cell interactions, this effect might have been
anticipated. The repair of oxidized lipids by proteins encoded
by mel2 could occur through a combination of epoxide hydro-
lase (melH) repair of lipid oxidative damage in the form of
lipid epoxides and oxidoreductase activities (melGIK) reducing
the LPO generated through the use of reduced flavin mono-
nucleotide, flavin adenine dinonucleotide, and NADH as co-
factors (62). Considering that the mel2 locus appears to play a
primary role in resistance to ROS and the degree of defect in
dissemination to the spleen is similar for both Phox/ and
iNOS/ mice, it is likely that the role of mel2 in host cell
infection is the primary factor that leads to an effect on dis-
semination. Further studies are needed to better differentiate
between these possibilities and evaluate how the mechanisms
of host cell infection can affect dissemination.
The mel2 locus does not appear to play a key role during the
early stages of infection when the innate immune response is
the primary mediator of bactericidal activity. Only after the
acquired immune system is active, at 4 weeks postinfection
when the production of TNF- and IFN- normally occurs (5,
32, 38), does the persistence of the mel2 mutant begin to
diverge from wild-type M. tuberculosis. At this stage of infec-
tion, one would expect that M. tuberculosis must cope with
activated macrophages that have migrated to the lung along
with a strong cell-mediated immune response. The role of
activated macrophages in the bactericidal mechanism involved
in clearing the mel2 mutant is supported by our tissue culture
studies using isolated primary and immortalized macrophages.
Although the mel2 mutant displays a severe defect for growth
in activated macrophages, growth in resting macrophages is
only reduced at later time points. These observations suggest
that the production of higher levels of ROS and/or RNS in
activated macrophages is the primary mechanism responsible,
since resting macrophages do not produce significant levels of
these bactericidal molecules unless bacteria are present. The
fact that the Phox/ activated macrophages and mice display
a less obvious phenotype than C57BL/6 or iNOS/ mice sug-
gests that the production of ROS by activated macrophages is
the primary mechanism by which the mel2 mutant is cleared
during the persistent stage of infection in mice.
Another interesting observation made during these studies is
that the pathological changes in the lungs and spleen are dif-
ferent between mice infected with wild-type M. tuberculosis
and the mel2 mutant. We had not expected differences at 4
weeks postinfection, since the numbers of bacteria present are
similar for the two bacterial strains at this time point. However,
the level of tissue damage and the numbers of granulomas
present were less for mice infected with the mel2 mutant than
for those infected with wild-type M. tuberculosis, suggesting
FIG. 10. LPO present in wild-type M. tuberculosis, mel2, and mel2-
complementing (mel2::pJDC75) strains after treatment with ROS.
Bacteria were treated with H2O2 or tert-butyl peroxide for 16 h. Data
shown are the means and standard deviations of the results from
triplicate samples in a representative experiment. Statistics shown are
for comparison between the untreated and treated groups as well as
the mel2 mutant compared to wild-type M. tuberculosis strains within
each group. Two asterisks indicate a P of 	0.01 and three asterisks
indicate a P of 	0.001, which are significantly different.
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that despite the same numbers of bacteria present, the disease
that the mel2 mutant causes is less severe. At 20 weeks postin-
fection, it is not surprising that the lung appears to be recov-
ering from infection, since bacterial numbers are usually at
least 10-fold lower for the mel2 mutant than wild-type M.
tuberculosis by this time point. A portion of the reduced pa-
thology in the lung may result from fewer mel2 mutant bacteria
in the spleen at the 4-week time point, as evidenced by fewer
foci of antigen-presenting cells containing bacteria until 20
weeks postinfection and by differences in CFU. This situation
may result in a less aggressive stimulation of the host immune
response via the spleen, reducing pathology resulting from the
host immune response. This effect does not appear to be det-
rimental to the ability of the host to mount a protective re-
sponse in the lung, since the mel2 mutant is cleared more
readily after 4 weeks, but it may reduce tissue damage. Re-
duced pathology and an inability to persist in the lung are
desirable characteristics for an attenuated vaccine strain, and
although the mel2 mutant may not be sufficiently attenuated to
be practical on its own, a double mutant with another locus and
mel2 may prove an advantageous strategy for design of a vac-
cine against M. tuberculosis, particularly since it would not be
attenuated to the point that it is unable to be protective. Stud-
ies are ongoing that compare the immune response in the lungs
and spleens of mel2 mutant- and wild-type-infected mice to
gain insight into potential differences in immune modulation
involving this locus.
The mel2 locus is required for the persistence of M. tuber-
culosis in mice after 4 weeks postinfection but does not affect
growth at earlier time points. This characteristic of the mutant
appears to be related to the mechanism by which M. tubercu-
losis resists ROS, a conclusion that is consistent with the sim-
ilarity of the genes in mel2 with bioluminescence systems in
other bacteria that have also been implicated in resistance to
ROS (2–4, 37, 63). The most likely biochemical mechanism for
the effect of mel2 on susceptibility to ROS is through a cata-
lase-like reaction, as has been observed with bioluminescence
systems where H2O2 is converted to H2O and light or an
oxidized intermediate (66). Since we have not observed light
production by M. tuberculosis in the presence of H2O2 (S.
Subbian and J. D. Cirillo, unpublished observations), we favor
the involvement of an oxidized intermediate whose precursor
is regenerated by the other genes in the mel2 locus, similarly to
luciferin in bioluminescence systems. The kinetics of the mel2
phenotype and its catalase-like activity could explain an earlier
observation that an M. tuberculosis katG mutant displays only a
transient phenotype, from 2 to 4 weeks postinfection (47), and
the presence of katG mutant isoniazid-resistant clinical isolates
(43, 45). Overall, these observations clarify the mechanisms of
ROS resistance during M. tuberculosis pathogenesis and sug-
gest that what may appear to be redundant systems can be
involved in different stages of disease, with the mel2 locus
playing a role in resistance to ROS during the chronic or
persistence stage of infection.
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